Statement of Deviation for period ended 31.03.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ridhi Synthetics Limited has submitted a routine compliance statement confirming that there has been no deviation or variation in the use of proceeds from its rights issue conducted on 11 January 2022, which raised Rs. 71.20 lakhs. Of the total amount, Rs. 48.50 lakhs was utilised for incremental working capital and Rs. 22.70 lakhs for issue expenses, fully matching the original objects. The statement was reviewed by the Audit Committee at its meeting held on 27 May 2025 and signed by Wholetime Director Vishal Chaturvedi. No monitoring agency was applicable for this issue.
This is a neutral, routine compliance filing with no material impact on the stock. It reassures shareholders that the company has used the rights issue proceeds strictly as originally disclosed, with no misuse or change in purpose.